Stay updated with breaking news from Pharming Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The plasma protease C1 inhibitor market size is forecasted to increase by USD 1.7 billion from 2021 to 2026, at a CAGR of 7.4%, according to...
/PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the first commercial shipments of Joenja® (leniolisib) to...
LEIDEN, Netherlands, April 11, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the first commercial shipments of Joenja® (leniolisib)
BlackRock Inc. - Pharming Group N.V. - Leiden BlackRock Inc. - Pharming Group N.V. - Leiden Below you will find information from the register... | April 11, 2023
Several brokerages have updated their recommendations and price targets on shares of Pharming Group (NASDAQ: PHAR) in the last few weeks: 3/29/2023 – Pharming Group is now covered by analysts at Royal Bank of Canada. They set an “outperform” rating on the stock. 3/28/2023 – Pharming Group had its price target raised by analysts at […]